Health and Healthcare

Wednesday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

BIONOVO INC [BNVI.OB] +24.42%
IOMAI CORPORATION [IOMI] +15.29%
GENITOPE CORPORATION [GTOP] +13.17%
ARTES MEDICAL, INC. [ARTE] +10.93%
MICROMET INC [MITI] +10.04%

Diagnostic Substances

SYNOVA HEALTHCARE GR [SNVH.OB] +12.00%
HEALTHCARE TECH LTD [HCTL] +4.94%
NYMOX PHARM CORP [NYMX] +3.52%
COLEY PHARMACEUTICAL [COLY] +2.46%
ASPENBIO PHARMA INC [APNB.OB] +2.46%

Drug Delivery

EMISPHERE TECH [EMIS] +8.19%
SKYEPHARMA PLC [SKYE] +6.04%
NOVADEL PHARMA INC [NVD] +5.26%
IOMED INC [IOX] +5.08%
INSITE VISION INC [ISV] +2.01%

Drug Manufacturers

PLANET TECHS INC [PLNT.OB] +23.97%
JAVELIN PHARMACEUTIC [JAV] +6.06%
ANGIOTECH PHARMA I [ANPI] +5.47%
NOVOGEN LTD ADS [NVGN] +5.09%
MARSHALL EDWARDS [MSHL] +5.00%

Medical Appliances & Equipment

ZOLL MEDICAL CP [ZOLL] +11.47%
CELSION CORP [CLN] +5.66%
SIGNALIFE INC [SGN] +5.33%
SHAMIR OPTICAL INDUS [SHMR] +4.61%
VNUS MEDICAL TECHNOL [VNUS] +4.51%

Medical Instruments & Supplies

UROPLASTY INC [UPI] +10.17%
EP MEDSYSTEMS INC [EPMD] +8.18%
ROCHESTER MEDICAL [ROCM] +7.98%
IMPLANT SCIENCES CP [IMX] +7.88%
CARDIAC SCIENCE CORP [CSCX] +6.58%

Medical Laboratories & Research

RADNET INC [RDNT.OB] +4.14%
BIO-REFERENCE LAB [BRLI] +2.06%
BIOFORCE NANOSCIENCE [BFNH.OB] +1.16%
PHARM PROD DEV [PPDI] +0.86%
AETERNA ZENTARIS [AEZS] +0.69%

http://www.biohealthinvestor.com/

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.